Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

June 2023

Volume 21Issue 3p317-418

Select all

Download started.
Ok

Please select at least one article in order to proceed.

A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer

Mehdi Kardoust Parizi,
Vitaly Margulis,
Yair Lotan,
Abdulmajeed Aydh,
Shahrokh F. Shariat

Published online: November 12, 2022

p317-323

The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis

Fernando Sabino Marques Monteiro,
Andrey Soares,
Alessandro Rizzo,
...
Veronica Mollica,
Enrique Grande,
Francesco Massari

Published online: January 19, 2023

p324-333

Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice

Deniz Tural,
Cagatay Arslan,
Fatih Selcukbiricik,
...
Dilek Erdem,
Nuri Karadurmus,
Saadettin Kilickap

Published online: December 19, 2022

p334-341

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

Added Clinical Value of ¹⁸F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

Noor van Ginkel,
Erik J. van Gennep,
Liselot Oosterbaan,
...
Theo M. de Reijke,
Bas W.G. van Rhijn,
Laura S. Mertens

Published online: February 21, 2023

p342-348

Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy

Antonin Broyelle,
Nicolas Delanoy,
André-Michel Bimbai,
...
Arnauld Villers,
Loïc Lebellec,
Stéphane Oudard

Published online: February 16, 2023

p349-356.e2

Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors

Hartlee Johnston,
Allison M. Deal,
Katherine P. Morgan,
Bianka Patel,
Matthew I. Milowsky,
Tracy L. Rose

Published online: February 15, 2023

p357-365

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

Emerson A. Lim,
Michael T. Schweizer,
Kim N. Chi,
...
Nibedita Bandyopadhyay,
Hong Xie,
Aaron R. Hansen

Published online: February 27, 2023

p366-375

Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey

Gagan Prakash,
Amandeep Arora,
Marco Bandini,
...
Viraj Master,
Curtis A Pettaway,
Philippe E Spiess

Published online: March 20, 2023

p376-382

Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer

Daniel J. George,
Fred Saad,
Michael S. Cookson,
...
David Buckley,
Bertrand Tombal,
Neal D. Shore

Published online: March 23, 2023

p383-392.e2

Open Access

Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism

David Gonilski-Pacin,
Nicolas Ciancio del Giudice,
Belen Elguero,
Eduardo Arzt

Published online: March 23, 2023

p393-402.e5

Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review

Bryan Khuong Le,
Patrick McGarrah,
Alan Paciorek,
...
Tiffany Le,
Emily Bergsland,
Thorvardur R. Halfdanarson

Published online: March 16, 2023

p403-414.e5

Open Access

The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer

Edward Lambert,
Nicolaas Lumen,
Valerie Fonteyne,
...
Geert Villeirs,
Kathia De Man,
Charles Van Praet

Published online: November 13, 2022

p415.e1-415.e8

The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management

Matteo Sacco,
Giorgio Gandaglia,
Kirsti Aas,
...
Paolo Gontero,
Giancarlo Marra
on behalf of The YAU Prostate Cancer Working Group

Published online: December 05, 2022

p416.e1-416.e10

First-Line Lenvatinib Plus Pembrolizumab or Everolimus versus Sunitinib for Advanced Renal Cell Carcinoma: A United States-Based Cost-Effectiveness Analysis

Youwen Zhu,
Kun Liu,
Dong Ding,
Libo Peng

Published online: November 24, 2022

p417.e1-417.e10

Open Access

The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit

Kristen McAlpine,
Roderick Clark,
Philippe E. Spiess,
Andrea Necchi,
Kenneth Gage,
Robert J. Hamilton

Published online: December 21, 2022

p418.e1-418.e6

Editorial Board

Published in issue: June 2023

A3-A7

Popular Articles

June 2023

Reviews

Original Studies

Editor’s highlight

Available Exclusively Online at www.clinical-genitourinary-cancer.com

Frontmatter